D.C. Region Reports Second-Highest Jump In Coronavirus Cases Since Last Month | WAMU
The uptick comes as some local officials have voiced concerns about a piecemeal reopening.
The uptick comes as some local officials have voiced concerns about a piecemeal reopening.
Our assessment of cancer immunotherapies (CIT) randomized controlled trials (RCTs) published over the last two years in major journals (Appendix 2) reveals that knowledge of…
Bristol Myers Squibb Announces Pivotal KRYSTAL-12 Confirmatory Trial Evaluating KRAZATI (adagrasib) Meets Primary Endpoint of Progression-Free Survival for Patients with Pretreated KRAS G12C-Mutated Locally Advanced…
Bristol Myers Squibb Announces Pivotal KRYSTAL-12 Confirmatory Trial Evaluating KRAZATI (adagrasib) Meets Primary Endpoint of Progression-Free Survival for Patients with Pretreated KRAS G12C-Mutated Locally Advanced…
Bristol Myers Squibb Announces Pivotal KRYSTAL-12 Confirmatory Trial Evaluating KRAZATI (adagrasib) Meets Primary Endpoint of Progression-Free Survival for Patients with Pretreated KRAS G12C-Mutated Locally Advanced…
Our assessment of cancer immunotherapies (CIT) randomized controlled trials (RCTs) published over the last two years in major journals (Appendix 2) reveals that knowledge of…
Given the low antitumour activity of existing treatment options in this patient population, trastuzumab deruxtecan might have the potential to fill a large unmet need…
The KRAS G12C inhibitor sotorasib was approved for the treatment of advanced NSCLC in the second line or later based on the CodeBreaK100 trial. However,…
The screening mammogram could be a “teachable moment” to improve lung cancer screening (LCS) uptake. The aim of our project was to combine patient self-referral…
MET proto-oncogene (MET) alterations are known driver oncogenes in non-small cell lung cancer (NSCLC). Since the identification of MET as a potential therapeutic target, extensive…
The identification of genomic ‘targets’ through next-generation sequencing (NGS) of patient’s NSCLC tumors has resulted in a rapid expansion of targeted treatment options for selected…